“The outlook revision reflects our assessment of SHC’s incrementally weaker financial profile, that while strong overall, is not consistent with a higher rating,” said S&P analyst Martin Arrick.
“The stable outlook reflects our view of SHC’s enterprise strengths and our expectation that finances will be maintained at least at the current level, given management’s efforts to rectify the slightly softer performance in the current year,” Mr. Arrick added.
More articles on healthcare finance:
Nebraska may owe CMS $32M in Medicaid reimbursements
Elavon launches payment software enhancements
4 ways to recruit and retain skilled RCM staff
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
